Abstract: A method for delivering therapeutic radiation to a target includes positioning a multi-aperture collimator on the skin within a trajectory of orthovoltage x-rays directed at the target, thus generating an array of minibeams, each of width between 0.1 mm to 0.6 mm. The skin is irradiated with the array. An effective beam of therapeutic radiation, which may be a solid beam, is delivered to the target at a predetermined tissue depth by merging adjacent orthovoltage x-ray minibeams sufficiently to form the effective beam. The effective beam may be formed proximal to the target. The depth at which the effective, preferably, solid, beam is formed is controlled by varying one or more of the spacing of the minibeams in the array, the minibeam width, the distance from the x-ray source to the collimator, and the x-ray source spot size. Planar minibeams can be arc-scanned while continuously modulating beam shape and intensity.
Type:
Grant
Filed:
September 26, 2018
Date of Patent:
October 27, 2020
Assignees:
The Research Foundation for State University of New York, The Board of Regents, The University of Texas System
Inventors:
F. Avraham Dilmanian, Sunil Krishnan, John Gordon Eley
Abstract: This invention features compositions, methods, and kits for treating conditions associated with pathological ocular neovascularization, reducing scarring in the eye, treating dry eye, treating macular degeneration, and treating keratitis by administering a serotonin receptor agonist.
Type:
Application
Filed:
May 1, 2018
Publication date:
October 22, 2020
Applicant:
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
Inventors:
Timothy Paul Foster, Charles David Nichols
Abstract: A method of preventing or reducing the occurrence and/or development of a hernia within a subject at risk of developing a hernia includes implanting a graft material in contact with an opening in an abdominal wall. The graft material promotes healing of the abdominal wall and includes placental or placental derived tissue.
Type:
Application
Filed:
March 27, 2020
Publication date:
October 22, 2020
Applicant:
The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Inventors:
Frank Ho Pak Lau, Ian Hodgdon, Michael Cook
Abstract: This disclosure provides methods and systems for classifying biological particles, e.g., blood cells, microbes, circulating tumor cells (CTCs). Using impedance flow cytometry, such as multi-frequency impedance cytometry, in conjunction with supervised machine learning, the disclosed methods and systems demonstrated improved accuracy in classifying biological particles.
Type:
Application
Filed:
April 17, 2020
Publication date:
October 22, 2020
Applicant:
Rutgers, The State University of New Jersey
Inventors:
Mehdi Javanmard, Karan Ahuja, Jianye Sui, Joseph R. Bertino
Abstract: Molecular probes for detecting and imaging pancreatic cancer are disclosed. The probes are modified benzoxanthene fluorophores, which are selectively taken up by pancreatic cancer cells, such as pancreatic ductal adenocarcinoma cells. Embodiments of the disclosed probes are useful for pancreatic cancer detection, therapeutic monitoring, and/or image-guided surgery.
Type:
Application
Filed:
May 23, 2017
Publication date:
October 22, 2020
Applicant:
Portland State University
Inventors:
Robert M Strongin, Martha Sibrian-Vazquez, Lei Wang, Jorge O. Escobedo Cordova, Mark A. Lowry
Abstract: A method of treating a bacterial infection including bacteria that have become resistant to an antibiotic in a subject in need thereof is provided. The method includes administering to the subject a safe and therapeutically effective amount of the antibiotic and a reviving agent selected from the group consisting of glass-ceramic particles, silver ions, and combinations thereof. The reviving agent restores antibiotic activity to the antibiotic against the bacteria.
Type:
Application
Filed:
March 27, 2020
Publication date:
October 22, 2020
Applicant:
Board of Trustees of Michigan State University
Inventors:
Xanthippi CHATZISTAVROU, Neal D. HAMMER, Aljoscha ROCH
Abstract: A rotary plasma reactor system is provided. In another aspect, a plasma reactor is rotatable about a generally horizontal axis within a vacuum chamber. A further aspect employs a plasma reactor, a vacuum chamber, and an elongated electrode internally extending within a central area of the reactor. Yet another aspect employs a plasma reactor for use in activating, etching and/or coating tumbling workpiece material.
Type:
Application
Filed:
January 15, 2020
Publication date:
October 22, 2020
Applicant:
Board of Trustees of Michigan State University
Abstract: The present application provides detectable compounds useful for identifying compounds that bind (e.g., inhibit) MmpL3. Methods of identifying compounds that bind and/or inhibit MmpL3 are also provided.
Type:
Application
Filed:
February 21, 2020
Publication date:
October 22, 2020
Applicants:
Creighton University, Colorado State University Research Foundation
Abstract: An optoelectronic semiconductor light source includes a semiconductor chip configured to emit primary radiation, a Bragg mirror, and a luminescence conversion element configured to convert at least part of the primary radiation into secondary radiation having a longer wavelength, wherein the Bragg mirror is arranged between the semiconductor chip and the luminescence conversion element, the Bragg mirror is reflective for the secondary radiation and transmissive for the primary radiation, the Bragg mirror includes reflector layers of at least three different materials with different refractive indices, the Bragg mirror includes at least two different kinds of layer pairs, each kind of layer pairs being made up of reflective layers of two different materials, and the different kinds of layer pairs having different Brewster angles for p-polarized radiation.
Type:
Grant
Filed:
March 4, 2019
Date of Patent:
October 20, 2020
Assignees:
OSRAM Opto Semiconductors GmbH, The Research Foundation For State University of New York
Abstract: A static volt-ampere reactive (VAR) compensator apparatus includes a capacitor electrically coupled between a phase conductor and a neutral conductor. The apparatus further includes a first switch electrically coupled between the phase conductor and an intermediate node. The apparatus also includes an inductor electrically coupled between the intermediate node and the neutral conductor in series with the first switch. The apparatus includes a second switch electrically coupled between the intermediate node and the neutral conductor in parallel with the inductor. The apparatus further includes a controller configured to transmit signals to the first switch and the second switch that cause the apparatus to modulate between a first state, in which the first switch is open and the second switch is closed, and a second state, in which the first switch is closed and the second switch is open.
Abstract: Disclosed are methods and systems that include obtaining at least one image of a dendritic structure, analyzing the at least one image to identify one or more features associated with the dendritic structure, and determining a numerical value associated with the dendritic structure based on the one or more features.
Type:
Grant
Filed:
November 6, 2015
Date of Patent:
October 20, 2020
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Abstract: An anti-neoplastic stable pharmaceutical composition comprising Temozolomide, high substituted polysaccharide phosphate in salt form, and high substituted polysaccharide phosphate in acidic form, in particular in a weight ratio of from 5 to 20% Temozolomide to 30 to 80% of polysaccharide in salt form, the reminder up to 100% being polysaccharide in acidic form. The level of 5-aminomidazole-4-carboxamide is below 0.5% by weight of Temozolomide in both the composition and the formulation disclosed. Also disclosed is a hydrogel for intrathecal administration obtainable by contacting the composition with sterile water, a method of manufacture of the composition and uses of the composition and the gel.
Type:
Grant
Filed:
April 28, 2017
Date of Patent:
October 20, 2020
Assignees:
Double Bond Pharmaceutical AB, Research Institute of Physical Chemical Problems of the Belarulsna State University
Abstract: An external urine collection system for collecting urine excreted by a female user through the female user's external urethral orifice includes a urinary assembly having a sleeve and a cup that define a collection chamber. The sleeve can be attached to an area around the female user's external urethral orifice by an adhesive. The cup can be coupled to the sleeve through a male connector and female connector that form a liquid tight seal between the sleeve and the cup. An outlet is defined by at least one of the sleeve and the cup for draining urine excreted by the user into the urinary assembly.
Type:
Grant
Filed:
March 24, 2017
Date of Patent:
October 20, 2020
Assignees:
Spectrum Health Innovation, LLC, Grand Valley State University
Inventors:
Eric Jon VanMiddendorp, Taylor S. Sims, Abby A. Merritt, Phillip N. Keshavarzi, Matthew S. Dykstra, Tyler D. Kramer, Amanda E. Stark, Chelsea M. Edge, Brandon D. Johnson, Jill M. Morris, John Farris, Andrew T. Heuerman, Kevin T. Weaver, Md Maruf Hossain
Abstract: Methods of isolating DNA of a fetus of an ongoing pregnancy are provided according to the present invention which include obtaining a maternal endocervical sample containing maternal cells and fetal extravillous trophoblast cells from a pregnant subject; isolating fetal extravillous trophoblast cells from the maternal endocervical sample, producing isolated fetal extravillous trophoblast cells contaminated with maternal DNA; lysing the isolated fetal extravillous trophoblast cells; isolating fetal nuclei from the lysed fetal extravillous trophoblast cells, producing isolated fetal nuclei, thereby removing at least a portion of the contaminating maternal DNA; and purifying genomic DNA from the isolated fetal nuclei, producing purified fetal genomic DNA. The purified fetal genomic DNA can be assayed to determine a characteristic of a genomic DNA sequence of the purified fetal genomic DNA, thereby determining a characteristic of DNA of a fetus of an ongoing pregnancy.
Abstract: Optically transmissive UV solar cells may be coupled to glass substrates, for example windows, in order to generate electricity while still providing suitable optical behavior for the window. The UV solar cells may be utilized to power electrochromic components coupled to the window to adjust or vary the transmissivity of the window. The UV solar cells may utilize a Schottky ZnO/ZnS heterojunction.
Type:
Grant
Filed:
July 25, 2017
Date of Patent:
October 20, 2020
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Inventors:
Hongbin Yu, Sandwip Dey, Xiao Di Sun Zhou, Ebraheem Azhar
Abstract: Systems and methods for quantitatively optimizing the design of prosthetic sockets are disclosed herein. An example method may involve receiving data indicating a first prosthetic socket design for a first patient and data associated with the first patient. The example method may also involve receiving data indicating a structure of an second prosthetic socket design for a second patient and data associated with the second patient. The example method may also involve determining, based on the data associated with the first patient, the data indicating the structure of the optimized prosthetic socket for the second patient, and the data associated with the second patient, an third prosthetic socket design for the first patient. The example method may also involve providing, based on the third prosthetic socket design for the first patient, an output indicating an area of the first prosthetic socket design to add or remove material.
Type:
Application
Filed:
April 10, 2020
Publication date:
October 15, 2020
Applicant:
The Florida State University Research Foundation, Inc.
Abstract: Provided herein are compounds of formula (I): and salts thereof. Also provided are pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula (I), and therapeutic methods for treating diseases such as cancer, a bacterial infection or a fungal infection using compounds of formula (I).
Type:
Application
Filed:
April 3, 2017
Publication date:
October 15, 2020
Applicant:
Rutgers, The State University of New Jersey
Abstract: A well plate for measuring an analyte in a sample is disclosed. The well plate includes at least a first, a second, and a third electrode. The first electrode has a higher sensitivity to a first analyte than the second and third electrodes. The second electrode has a higher sensitivity to a second analyte than the first and third electrodes.
Type:
Application
Filed:
April 11, 2020
Publication date:
October 15, 2020
Applicant:
Colorado State University Research Foundation
Inventors:
Thomas W. Chen, Daniel S. Ball, Caleb R. Begly